BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31105001)

  • 1. Mortality in patients with high risk Staphylococcus aureus bacteremia undergoing or not PET-CT: A single center experience.
    Yildiz H; Reychler G; Rodriguez-Villalobos H; Orioli L; D'Abadie P; Vandeleene B; Danse E; Vandercam B; Pasquet A; Yombi JC
    J Infect Chemother; 2019 Nov; 25(11):880-885. PubMed ID: 31105001
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Berrevoets MAH; Kouijzer IJE; Aarntzen EHJG; Janssen MJR; De Geus-Oei LF; Wertheim HFL; Kullberg BJ; Oever JT; Oyen WJG; Bleeker-Rovers CP
    J Nucl Med; 2017 Sep; 58(9):1504-1510. PubMed ID: 28336786
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Berrevoets MAH; Kouijzer IJE; Slieker K; Aarntzen EHJG; Kullberg BJ; Oever JT; Bleeker-Rovers CP
    J Nucl Med; 2019 Jul; 60(7):998-1002. PubMed ID: 30552202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of FDG-PET/CT in the Diagnostic Workup for Staphylococcus aureus Bacteremia: A Prospective Interventional Matched-cohort Study.
    Ghanem-Zoubi N; Kagna O; Abu-Elhija J; Mustafa-Hellou M; Qasum M; Keidar Z; Paul M
    Clin Infect Dis; 2021 Dec; 73(11):e3859-e3866. PubMed ID: 32639560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [18F]FDG-PET/CT in Staphylococcus aureus bacteremia: a systematic review.
    Buis DTP; Sieswerda E; Kouijzer IJE; Huynh WY; Burchell GL; Berrevoets MAH; Prins JM; Sigaloff KCE
    BMC Infect Dis; 2022 Mar; 22(1):282. PubMed ID: 35331165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive Impact of [18F]FDG-PET/CT on Mortality in Patients With Staphylococcus aureus Bacteremia Explained by Immortal Time Bias.
    van der Vaart TW; Prins JM; van Werkhoven CH; Ten Doesschate T; Soetekouw R; van Twillert G; Veenstra J; Herpers BL; Rozemeijer W; Jansen RR; Bonten MJM; van der Meer JTM
    Clin Infect Dis; 2023 Jul; 77(1):9-15. PubMed ID: 36869816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term mortality and causes of death associated with Staphylococcus aureus bacteremia. A matched cohort study.
    Gotland N; Uhre ML; Mejer N; Skov R; Petersen A; Larsen AR; Benfield T;
    J Infect; 2016 Oct; 73(4):346-57. PubMed ID: 27418382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of Clinical Impact Supports a New Petition for Medicare Coverage of 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in the Evaluation of Staphylococcus aureus Bacteremia: A Focused Literature Review and Call to Action.
    Thottacherry E; Cortés-Penfield NW
    Clin Infect Dis; 2022 Oct; 75(8):1457-1461. PubMed ID: 35535794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB).
    Sohail MR; Palraj BR; Khalid S; Uslan DZ; Al-Saffar F; Friedman PA; Hayes DL; Lohse CM; Wilson WR; Steckelberg JM; Baddour LM
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):137-44. PubMed ID: 25504648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
    Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
    Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes increases the risk of disease and death due to Staphylococcus aureus bacteremia. A matched case-control and cohort study.
    Hansen MU; Gotland N; Mejer N; Petersen A; Larsen AR; Benfield T;
    Infect Dis (Lond); 2017 Sep; 49(9):689-697. PubMed ID: 28535702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of correlation of virulence gene profiles of Staphylococcus aureus bacteremia isolates with mortality.
    Park KH; Greenwood-Quaintance KE; Cunningham SA; Rajagopalan G; Chia N; Jeraldo PR; Mandrekar J; Patel R
    Microb Pathog; 2019 Aug; 133():103543. PubMed ID: 31102653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased overall survival after introduction of structured bedside consultation in Staphylococcus aureus bacteraemia.
    Ariaans MBPA; Roovers EA; Claassen MAA; Hassing RJ; Swanink CMA; Gisolf EH
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1187-1193. PubMed ID: 29671174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic infectious disease and clinical outcome in Staphylococcus aureus and Streptococcus species bacteremia.
    Vos FJ; Kullberg BJ; Sturm PD; Krabbe PFM; van Dijk APJ; Wanten GJA; Oyen WJG; Bleeker-Rovers CP
    Medicine (Baltimore); 2012 Mar; 91(2):86-94. PubMed ID: 22391470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for late Staphylococcus aureus bacteremia after allogeneic hematopoietic stem cell transplantation: a single-institution, nested case-controlled study.
    Mihu CN; Schaub J; Kesh S; Jakubowski A; Sepkowitz K; Pamer EG; Papanicolaou GA
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1429-33. PubMed ID: 19041067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualizing the use of [
    van Leerdam EJ; Gompelman M; Tuinte RAM; Aarntzen EHJG; Berrevoets MAH; Maat I; Bleeker-Rovers CP; van Crevel R; Ten Oever J; Kouijzer IJE
    Infection; 2022 Apr; 50(2):491-498. PubMed ID: 34928493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Septic pulmonary emboli detected by
    Méndez-Echevarria A; Coronado-Poggio M; Baquero-Artigao F; Del Rosal T; Rodado-Marina S; Calvo C; Domínguez-Gadea L
    Infection; 2017 Oct; 45(5):691-696. PubMed ID: 28243995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of FDG-PET/CT in bacteremia of unknown origin with catalase-negative gram-positive cocci or Staphylococcus aureus.
    Brøndserud MB; Pedersen C; Rosenvinge FS; Høilund-Carlsen PF; Hess S
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1351-1358. PubMed ID: 30788532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
    Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
    Trials; 2019 May; 20(1):250. PubMed ID: 31046810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
    Kim SH; Park WB; Lee KD; Kang CI; Kim HB; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2003 Sep; 37(6):794-9. PubMed ID: 12955640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.